By Dr. Mercola
Drug companies are often portrayed as benevolent companies that pour billions of dollars into the creation of new drugs and vaccinations for the greater good. This was certainly the case in a New York Times column on the antiviral drug remdesivir, which has shown some promise in treating COVID-19.1
Biotech giant Gilead Sciences, which produces the drug, began distributing it on a compassionate-use basis in January 2020. Compassionate use is a form of expanded access to a drug, describing “the individual patient use of an investigational medicinal product outside of a clinical trial that is intended to treat a serious …read more
Source: mercola
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr